a.reyes
TL4 Administrator Co-founder · Governance · Lisbon, PT
Co-founded The Peptide Commons in May 2024 to see whether a peptide community could be run in the open. I write and maintain the guidelines, publish the moderation log, and answer anything about how this place is governed. I am not a clinician and I do not give dosing advice.
Joined 18 May 2024 · last posted 21h · groups: staff, moderators, wiki-editors, trust-level-4
205 posts, newest first. Showing up to 150.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #100 · Access › Insurance & coverage · 27 Jul 2026 · 3 likes Coming back to post #98, because the follow-up matters more than the original answer. Generic versus brand: most of these compounds do not have generic versions yet.…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #27 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Purity and content are different measurements: purity tells you what proportion of the detected…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #29 · Compounds › Oral incretins · 26 Jul 2026 · 20 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Seven-day rolling means and why weekly readings mislead Replied, post #94 · Outcomes › Progress reports · 23 Jul 2026 · 5 likes Coming back to post #92, because the follow-up matters more than the original answer. Measurement noise: day-to-day body mass varies by more than a kilogram on…
-
How shortages have affected compounding permissions Replied, post #62 · Access › Shortages · 23 Jul 2026 · 12 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Priming a pen and whether the primed volume is wasted Replied, post #19 · Devices › Pens & autoinjectors · 23 Jul 2026 · 2 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #50 · Compounds › Secretagogues & GH axis · 23 Jul 2026 · 10 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Seven-day rolling means and why weekly readings mislead Replied, post #75 · Outcomes › Progress reports · 21 Jul 2026 · 3 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #28 · Sourcing › Vendor reports · 20 Jul 2026 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #16 · Analytics › COA interpretation · 17 Jul 2026 · 18 likes post #15 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 15 Jul 2026 · 11 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #21 · Practice › Side effects · 14 Jul 2026 · 18 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Which categories are strict and which are relaxed, honestly Replied, post #8 · Start Here › Welcome · 12 Jul 2026 · 5 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Submitting a sample: the process end to end Replied, post #63 · Sourcing › Independent verification · 6 Jul 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Forced degradation studies: designing one that is informative Replied, post #91 · Analytics › Method validation · 5 Jul 2026 · 1 like I read post #89 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #79 · Compounds › Semaglutide · 26 Jun 2026 · 1 like The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #15 · Compounds › Retatrutide · 24 Jun 2026 · 14 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
[2026 update] Correlation in a self-tracked dataset: what it can support Replied, post #2 · Research Methods › Statistics · 21 Jun 2026 · 0 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
What I would want from a home test that does not exist yet Replied, post #9 · Analytics › Home & field testing · 12 Jun 2026 · 11 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #93 · Outcomes › Body composition · 11 Jun 2026 · 20 likes I read post #91 twice before replying, because I had assumed the opposite. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training…
-
A checklist for reading a certificate in under two minutes Replied, post #38 · Analytics › COA interpretation · 11 Jun 2026 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Racemisation and why it is invisible to a mass measurement Replied, post #13 · Analytics › Impurities & related substances · 8 Jun 2026 · 2 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #20 · Pharmacology › Pharmacokinetics · 8 Jun 2026 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Bioimpedance and hydration: why the number moves Replied, post #56 · Outcomes › Body composition · 6 Jun 2026 · 0 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #82 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Picking up post #79: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
What a certificate commits its issuer to — one year on Replied, post #82 · Analytics › COA interpretation · 5 Jun 2026 · 17 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #54 · Access › Insurance & coverage · 5 Jun 2026 · 0 likes Worth separating two things that post #50 runs together. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates,…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #40 · Practice › Storage & stability · 4 Jun 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Revisiting: The best-written scientific paper you have read Replied, post #13 · Lounge › Off topic · 3 Jun 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Publication patterns in the BPC-157 literature, examined Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 2 Jun 2026 · 11 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #34 · Compounds › Repair & healing peptides · 31 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
CJC-1295 with and without DAC: what the modification does Replied, post #68 · Compounds › Secretagogues & GH axis · 27 May 2026 · 9 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #24 · Clinical › Special populations · 25 May 2026 · 30 likes On post #20 — agreed on the reasoning, with one qualification. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes…
-
Moderation log format change Replied, post #54 · Meta › Announcements · 19 May 2026 · 8 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Tracking a shortage from primary sources rather than rumour Replied, post #5 · Access › Shortages · 10 May 2026 · 2 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #24 · Analytics › Home & field testing · 8 May 2026 · 10 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #43 · Evidence › Journal club · 7 May 2026 · 0 likes post #42 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #42 · Meta › Announcements · 6 May 2026 · 33 likes Coming back to post #40, because the follow-up matters more than the original answer. Staff-only posts: some announcements are visible only to staff (concerning…
-
Historical amylin analogues and what happened to them Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 4 May 2026 · 16 likes post #4 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #4 · Compounds › Retatrutide · 2 May 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #9 · Sourcing › Independent verification · 2 May 2026 · 11 likes This follows post #6 rather than contradicting it. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #19 · Analytics › Home & field testing · 29 Apr 2026 · 26 likes Picking up post #16: that is the part I would want checked first. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Started this topic · Documentation › Doc review · 28 Apr 2026 · 10 likes Posting this under the heading it deserves: Review: a draft on reconstitution arithmetic, with objections — what changed since Everything below is what sits behind…
-
Electrolyte supplements: which ones do anything Started this topic · Nutrition & Training › Hydration & electrolytes · 27 Apr 2026 · 6 likes On the subject in the title: Electrolyte supplements: which ones do anything Working notes rather than a conclusion. Maintenance rather than loss, which is the part of…
-
Prescription portability between countries Replied, post #15 · Access › International · 24 Apr 2026 · 0 likes This follows post #12 rather than contradicting it. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by…
-
Blinding yourself: practical methods and their limits Replied, post #20 · Research Methods › N-of-1 designs · 23 Apr 2026 · 9 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Why the timeline is on the right and not the left — what changed since Replied, post #24 · Meta › Site feedback · 22 Apr 2026 · 5 likes Picking up post #21: that is the part I would want checked first. Search and findability: if you searched for something and did not find it, report what you searched…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #43 · Devices › Syringes & needles · 19 Apr 2026 · 33 likes post #42 is right about the mechanism and I think understates the practical bit. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
CJC-1295 with and without DAC: what the modification does Replied, post #37 · Compounds › Secretagogues & GH axis · 19 Apr 2026 · 13 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #115 · Clinical › Special populations · 18 Apr 2026 · 2 likes Picking up post #112: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #85 · Compounds › Tirzepatide · 16 Apr 2026 · 5 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Prescription portability between countries Replied, post #9 · Access › International · 16 Apr 2026 · 28 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Spike-and-recover accuracy for a peptide assay Replied, post #29 · Analytics › Method validation · 7 Apr 2026 · 0 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Bioimpedance and hydration: why the number moves Replied, post #27 · Outcomes › Body composition · 6 Apr 2026 · 1 like Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #32 · Outcomes › Body composition · 6 Apr 2026 · 6 likes post #31 is right about the mechanism and I think understates the practical bit. Changes during titration: measuring body composition during active titration is less…
-
The "under review" status pill and when a moderator applies it Replied, post #39 · Evidence › Preprints · 26 Mar 2026 · 14 likes On post #35 — agreed on the reasoning, with one qualification. Discussing preprints in this community: bring them in for early discussion, label them clearly as…
-
Journal club: is percentage weight change the right endpoint? Replied, post #15 · Evidence › Journal club · 26 Mar 2026 · 1 like post #14 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #80 · Compounds › Semaglutide · 19 Mar 2026 · 30 likes On post #76 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Why this subcategory is stricter about sourcing than most Replied, post #9 · Compounds › Secretagogues & GH axis · 18 Mar 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #6 · Clinical › Comorbidities · 13 Mar 2026 · 16 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #27 · Lounge › Introductions · 10 Mar 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
The lowest dose that does anything: is that a real question? Replied, post #111 · Practice › Dosing & titration · 8 Mar 2026 · 30 likes post #110 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #13 · Practice › Dosing & titration · 7 Mar 2026 · 13 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 0 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #101 · Access › Pricing · 27 Feb 2026 · 1 like International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #33 · Practice › Interactions · 26 Feb 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #48 · Analytics › Mass spectrometry · 24 Feb 2026 · 23 likes On post #44 — agreed on the reasoning, with one qualification. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #134 · Practice › Dosing & titration · 22 Feb 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #76 · Clinical › Bloodwork · 14 Feb 2026 · 4 likes Picking up post #73: that is the part I would want checked first. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin…
-
Amylin receptor signalling and satiety — what changed since Replied, post #29 · Pharmacology › Receptor biology · 12 Feb 2026 · 1 like post #28 is right about the mechanism and I think understates the practical bit. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
-
Trifluoroacetate content and its consequences Replied, post #82 · Analytics › Impurities & related substances · 4 Feb 2026 · 0 likes post #81 answers the question as asked. The question underneath it is different. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a…
-
Waist circumference technique and its repeatability Replied, post #46 · Outcomes › Progress reports · 2 Feb 2026 · 23 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Managing an unplanned gap in supply Replied, post #15 · Access › Shortages · 27 Jan 2026 · 3 likes This follows post #12 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
MHRA statements, read directly Replied, post #76 · Regional › UK & Ireland · 26 Jan 2026 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and…
-
Request: export my own posts — one year on Replied, post #38 · Meta › Feature requests · 25 Jan 2026 · 1 like Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Personal import allowances, compared — a second dataset Replied, post #56 · Access › International · 22 Jan 2026 · 14 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #11 · Practice › Administration · 21 Jan 2026 · 15 likes Worth separating two things that post #7 runs together. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #35 · Outcomes › Body composition · 3 Jan 2026 · 1 like Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Coverage in the US: a map of the usual obstacles Replied, post #30 · Regional › North America · 1 Jan 2026 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Reading an interaction checker output critically Replied, post #74 · Practice › Interactions · 24 Dec 2025 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #21 · Clinical › Bloodwork · 2 Dec 2025 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. TSH and free hormones: TSH is a reasonable screening test but does not tell you about…
-
A parcel stationary at a customs facility for nine days Replied, post #7 · Sourcing › Logistics · 24 Nov 2025 · 31 likes post #6 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #135 · Start Here › How to Ask · 24 Nov 2025 · 17 likes Worth separating two things that post #131 runs together. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
Reading SURMOUNT-1 without the press release Replied, post #75 · Compounds › Tirzepatide · 22 Nov 2025 · 11 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #26 · Practice › Storage & stability · 22 Nov 2025 · 7 likes Picking up post #23: that is the part I would want checked first. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #42 · Sourcing › Regulatory · 21 Nov 2025 · 24 likes On post #38 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #4 · Practice › Side effects · 21 Nov 2025 · 24 likes On the opening post — agreed on the reasoning, with one qualification. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training…
-
Availability by country, dated, with primary sources Replied, post #65 · Access › International · 18 Nov 2025 · 6 likes post #64 answers the question as asked. The question underneath it is different. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
Reading an interaction checker output critically Replied, post #38 · Practice › Interactions · 7 Nov 2025 · 21 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #15 · Sourcing › Regulatory · 4 Nov 2025 · 4 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
A comparison of home results against a laboratory result on the same vial Replied, post #58 · Analytics › Home & field testing · 4 Nov 2025 · 2 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #61 · Pharmacology › Receptor biology · 3 Nov 2025 · 2 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #27 · Start Here › How to Ask · 28 Oct 2025 · 8 likes Worth separating two things that post #23 runs together. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #78 · Sourcing › Vendor reports · 23 Oct 2025 · 3 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
A 40-week log with the measurement method stated Replied, post #40 · Outcomes › Progress reports · 20 Oct 2025 · 20 likes Picking up post #37: that is the part I would want checked first. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain)…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #5 · Start Here › How to Ask · 17 Oct 2025 · 18 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
When to stop reading forums, including this one Replied, post #36 · Wellbeing › Mental health · 13 Oct 2025 · 1 like Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Meeting a protein target on a suppressed appetite Replied, post #26 · Nutrition & Training › Protein & intake · 5 Oct 2025 · 2 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #49 · Evidence › Preprints · 29 Sep 2025 · 5 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Payment method and the leverage it gives you, ranked Replied, post #63 · Sourcing › Payments · 23 Sep 2025 · 15 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #2 · Compounds › Tirzepatide · 15 Sep 2025 · 3 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Severe abdominal pain: why this is not a forum question — one year on Started this topic · Safety › Adverse events · 10 Sep 2025 · 31 likes Severe abdominal pain: why this is not a forum question — one year on — setting out what I have, and where I think it stops being reliable. General question, not a…
-
Hypertension improvement and when medication needs revisiting Replied, post #52 · Clinical › Comorbidities · 10 Sep 2025 · 0 likes Worth separating two things that post #48 runs together. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without…
-
Risk-of-bias tools and the judgement they conceal Replied, post #13 · Evidence › Meta-analyses · 5 Sep 2025 · 9 likes This follows post #10 rather than contradicting it. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #33 · Compounds › Oral incretins · 31 Aug 2025 · 2 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Confounding by indication, explained with a concrete example Replied, post #2 · Evidence › Study critique · 30 Aug 2025 · 1 like Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #31 · Compounds › Tirzepatide · 29 Aug 2025 · 16 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 25 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #28 · Analytics › Mass spectrometry · 14 Aug 2025 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. Desalting before analysis: some samples need desalting to remove salts that suppress…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #2 · Evidence › Preprints · 9 Aug 2025 · 15 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 8 Aug 2025 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #22 · Practice › Storage & stability · 7 Aug 2025 · 29 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
A ten-fold dose error caught before injection — one year on Replied, post #149 · Devices › Syringes & needles · 5 Aug 2025 · 22 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #17 · Practice › Storage & stability · 31 Jul 2025 · 2 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #24 · Compounds › Secretagogues & GH axis · 31 Jul 2025 · 0 likes post #23 answers the question as asked. The question underneath it is different. Development history is more informative than speculation: ipamorelin was investigated…
-
Reading a denial letter as a specification for your appeal Replied, post #3 · Access › Insurance & coverage · 26 Jul 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #147 · Devices › Cold chain · 21 Jul 2025 · 0 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
About the Administration category Replied, post #5 · Practice › Administration · 17 Jul 2025 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #137 · Compounds › Tirzepatide · 15 Jul 2025 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Sequence verification for an obscure compound: how it is done Replied, post #84 · Compounds › Other compounds · 6 Jul 2025 · 3 likes post #83 is right about the mechanism and I think understates the practical bit. Reading a supplier's product description as a marketing document: that is exactly what…
-
A supplier that answers analytical questions with restated claims Replied, post #111 · Sourcing › Red flags · 5 Jul 2025 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Sodium, potassium and magnesium when intake drops Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 2 Jul 2025 · 23 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #20 · Data & Tools › Datasets · 1 Jul 2025 · 5 likes post #19 is right about the mechanism and I think understates the practical bit. Privacy: if contributing data, only share data you are comfortable making permanent and…
-
AOD-9604 and the fragment hypothesis, revisited Started this topic · Compounds › Other compounds · 20 Jun 2025 · 0 likes Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #118 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 32 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Half-life, steady state, and accumulation worked through Replied, post #126 · Pharmacology › Pharmacokinetics · 16 Jun 2025 · 26 likes I read post #124 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #10 · Practice › Reconstitution · 11 Jun 2025 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A claim built entirely on a subgroup analysis Replied, post #77 · Evidence › Study critique · 5 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pre-registering a personal experiment, seriously Replied, post #119 · Research Methods › N-of-1 designs · 4 Jun 2025 · 9 likes Worth separating two things that post #115 runs together. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach.…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 31 May 2025 · 14 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Pre-registering a personal experiment, seriously Replied, post #57 · Research Methods › N-of-1 designs · 30 May 2025 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Gauge and length selection for subcutaneous injection Replied, post #2 · Devices › Syringes & needles · 30 May 2025 · 10 likes the opening post answers the question as asked. The question underneath it is different. Reading units correctly: look at the marking from the side, not from above or…
-
Half-life, steady state, and accumulation worked through Replied, post #31 · Pharmacology › Pharmacokinetics · 27 May 2025 · 1 like This follows post #28 rather than contradicting it. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #37 · Evidence › Journal club · 23 May 2025 · 10 likes I read post #35 twice before replying, because I had assumed the opposite. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
-
A report I filed that turned out to be wrong, and the correction Replied, post #63 · Sourcing › Vendor reports · 21 May 2025 · 1 like I read post #61 twice before replying, because I had assumed the opposite. Date the report: when the analysis was done matters. Material can degrade in storage. A…
-
A report I filed that turned out to be wrong, and the correction Replied, post #56 · Sourcing › Vendor reports · 16 May 2025 · 0 likes Worth separating two things that post #52 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #41 · Devices › Pens & autoinjectors · 15 May 2025 · 15 likes Worth separating two things that post #37 runs together. Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty.…
-
Counter-ion content and its effect on measured mass Replied, post #39 · Analytics › Mass spectrometry · 15 May 2025 · 6 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Water content on a certificate and why it changes the arithmetic Replied, post #19 · Analytics › COA interpretation · 12 May 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
A claim built entirely on a subgroup analysis Replied, post #28 · Evidence › Study critique · 11 May 2025 · 33 likes Picking up post #25: that is the part I would want checked first. Confounding: in observational data, is there a third variable that explains the apparent association?…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #15 · Clinical › Bloodwork · 30 Apr 2025 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Reference intervals: constructed to contain the central 95% of a reference population,…
-
Reading a chromatogram someone posted without axes Replied, post #27 · Analytics › HPLC & UHPLC · 30 Apr 2025 · 19 likes On post #23 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Dizziness on standing: the ordinary explanation first Replied, post #23 · Nutrition & Training › Hydration & electrolytes · 28 Apr 2025 · 0 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Requesting a page: what makes a good request Replied, post #71 · Documentation › Wiki requests · 26 Apr 2025 · 1 like Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #65 · Analytics › Mass spectrometry · 13 Apr 2025 · 8 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Carryover and the ghost peak from last week's standard Replied, post #67 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 8 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Reading order for a first week here, and what to skip until later Replied, post #67 · Start Here › Welcome · 4 Apr 2025 · 2 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #14 · Practice › Dosing & titration · 20 Mar 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #13 · Evidence › Trials · 17 Mar 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #42 · Compounds › Semaglutide · 17 Mar 2025 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…